Bioactive constituents from the green alga Caulerpa racemosa

[Display omitted] Three diterpenoids, including a pair of epimers, racemobutenolids A and B (1 and 2), and 4′,5′-dehydrodiodictyonema A (3), an α-tocopheroid, α-tocoxylenoxy (8), and an 28-oxostigmastane steroid, (23E)-3β-hydroxy-stigmasta-5,23-dien-28-one (11), together with 12 known compounds, wer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2015-01, Vol.23 (1), p.38-45
Hauptverfasser: Yang, Peng, Liu, Ding-Quan, Liang, Tong-Jun, Li, Jia, Zhang, Hai-Yan, Liu, Ai-Hong, Guo, Yue-Wei, Mao, Shui-Chun
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 45
container_issue 1
container_start_page 38
container_title Bioorganic & medicinal chemistry
container_volume 23
creator Yang, Peng
Liu, Ding-Quan
Liang, Tong-Jun
Li, Jia
Zhang, Hai-Yan
Liu, Ai-Hong
Guo, Yue-Wei
Mao, Shui-Chun
description [Display omitted] Three diterpenoids, including a pair of epimers, racemobutenolids A and B (1 and 2), and 4′,5′-dehydrodiodictyonema A (3), an α-tocopheroid, α-tocoxylenoxy (8), and an 28-oxostigmastane steroid, (23E)-3β-hydroxy-stigmasta-5,23-dien-28-one (11), together with 12 known compounds, were isolated from the green alga Caulerpa racemosa. The structures of the new compounds were elucidated by detailed analysis of spectroscopic data, and by comparison with data for related known compounds. The epimers (1 and 2) are two unusual diterpenoid lactones bearing a β-methyl-γ-substituted butenolide moiety, and 3 and 8 represent the first naturally occurring natural products with a hematinic acid ester group and 3,5-dimethylphenoxy functionality, respectively. The enzyme inhibitory activities of the isolated compounds were evaluated in vitro against PTP1B and related PTPs (TCPTP, CDC25B, LAR, SHP-1, and SHP-2). Compounds 3, 5, 6, and 9–14 exhibited different levels of PTP1B inhibitory activities with IC50 values ranging from 2.30 to 50.02μM. Of these compounds, 3, 9, and 11 showed the most potent inhibitory activities towards PTP1B with IC50 values of 2.30, 3.85, and 3.80μM, respectively. More importantly, the potent PTP1B inhibitors 3, 9, and 11 also displayed high selectivity over the highly homologous TCPTP and other PTPs. Also, the neuroprotective effects of the isolates against Aβ25-35-induced cell damage in SH-SY5Y cells were investigated. Compounds 10, 11, and 14 exhibited significant neuroprotective effects against Aβ25-35-induced SH-SY5Y cell damage with 11.31–15.98% increases in cell viability at 10μM. In addition, the cytotoxic activities of the isolated compounds were tested against the human cancer cell lines A-549 and HL-60.
doi_str_mv 10.1016/j.bmc.2014.11.031
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1660403889</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089614008189</els_id><sourcerecordid>1660403889</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-47e402e0e93ca315f29209053d881885a057b2e058fa86bbd5f571b4427fbf903</originalsourceid><addsrcrecordid>eNqNkDtv2zAURokiReO4_QFdAo1ZpN7Lh0SiXRKjTQsEyJLMBEVduTT0cEgpQP59ZdjNGGS6wz3fGQ5jXxEKBCy_7Yq69wUHlAViAQI_sBXKUuZCGDxjKzClzkGb8pxdpLQDAC4NfmLnXElTmVKs2I-bMDo_hWfK_DikKUwzDVPK2jj22fSXsm0kGjLXbV22cXNHce-y6Dz1Y3Kf2cfWdYm-nO6aPf76-bD5nd_d3_7ZXN_lXio-5bIiCZyAjPBOoGq54WBAiUZr1Fo5UFW9_JVunS7rulGtqrCWkldt3RoQa3Z19O7j-DRTmmwfkqeucwONc7JYliBBaG3egQpjqkpyuaB4RH0cU4rU2n0MvYsvFsEe-tqdXfraQ1-LaJe-y-bypJ_rnprXxf-gC_D9CNDS4zlQtMkHGjw1IZKfbDOGN_T_AJVYiQo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1639977424</pqid></control><display><type>article</type><title>Bioactive constituents from the green alga Caulerpa racemosa</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Yang, Peng ; Liu, Ding-Quan ; Liang, Tong-Jun ; Li, Jia ; Zhang, Hai-Yan ; Liu, Ai-Hong ; Guo, Yue-Wei ; Mao, Shui-Chun</creator><creatorcontrib>Yang, Peng ; Liu, Ding-Quan ; Liang, Tong-Jun ; Li, Jia ; Zhang, Hai-Yan ; Liu, Ai-Hong ; Guo, Yue-Wei ; Mao, Shui-Chun</creatorcontrib><description>[Display omitted] Three diterpenoids, including a pair of epimers, racemobutenolids A and B (1 and 2), and 4′,5′-dehydrodiodictyonema A (3), an α-tocopheroid, α-tocoxylenoxy (8), and an 28-oxostigmastane steroid, (23E)-3β-hydroxy-stigmasta-5,23-dien-28-one (11), together with 12 known compounds, were isolated from the green alga Caulerpa racemosa. The structures of the new compounds were elucidated by detailed analysis of spectroscopic data, and by comparison with data for related known compounds. The epimers (1 and 2) are two unusual diterpenoid lactones bearing a β-methyl-γ-substituted butenolide moiety, and 3 and 8 represent the first naturally occurring natural products with a hematinic acid ester group and 3,5-dimethylphenoxy functionality, respectively. The enzyme inhibitory activities of the isolated compounds were evaluated in vitro against PTP1B and related PTPs (TCPTP, CDC25B, LAR, SHP-1, and SHP-2). Compounds 3, 5, 6, and 9–14 exhibited different levels of PTP1B inhibitory activities with IC50 values ranging from 2.30 to 50.02μM. Of these compounds, 3, 9, and 11 showed the most potent inhibitory activities towards PTP1B with IC50 values of 2.30, 3.85, and 3.80μM, respectively. More importantly, the potent PTP1B inhibitors 3, 9, and 11 also displayed high selectivity over the highly homologous TCPTP and other PTPs. Also, the neuroprotective effects of the isolates against Aβ25-35-induced cell damage in SH-SY5Y cells were investigated. Compounds 10, 11, and 14 exhibited significant neuroprotective effects against Aβ25-35-induced SH-SY5Y cell damage with 11.31–15.98% increases in cell viability at 10μM. In addition, the cytotoxic activities of the isolated compounds were tested against the human cancer cell lines A-549 and HL-60.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2014.11.031</identifier><identifier>PMID: 25497963</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biological Products ; Caulerpa - chemistry ; Caulerpa racemosa ; Cytotoxic activity ; Diterpenes - chemistry ; Diterpenes - pharmacology ; HL-60 Cells ; Humans ; Molecular Structure ; Neuroprotective activity ; Neuroprotective Agents - chemistry ; Neuroprotective Agents - pharmacology ; Plant Extracts - chemistry ; Plant Extracts - pharmacology ; PTP1B inhibitory activity ; Structure-Activity Relationship</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2015-01, Vol.23 (1), p.38-45</ispartof><rights>2014 Elsevier Ltd</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-47e402e0e93ca315f29209053d881885a057b2e058fa86bbd5f571b4427fbf903</citedby><cites>FETCH-LOGICAL-c452t-47e402e0e93ca315f29209053d881885a057b2e058fa86bbd5f571b4427fbf903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0968089614008189$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25497963$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Peng</creatorcontrib><creatorcontrib>Liu, Ding-Quan</creatorcontrib><creatorcontrib>Liang, Tong-Jun</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><creatorcontrib>Zhang, Hai-Yan</creatorcontrib><creatorcontrib>Liu, Ai-Hong</creatorcontrib><creatorcontrib>Guo, Yue-Wei</creatorcontrib><creatorcontrib>Mao, Shui-Chun</creatorcontrib><title>Bioactive constituents from the green alga Caulerpa racemosa</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>[Display omitted] Three diterpenoids, including a pair of epimers, racemobutenolids A and B (1 and 2), and 4′,5′-dehydrodiodictyonema A (3), an α-tocopheroid, α-tocoxylenoxy (8), and an 28-oxostigmastane steroid, (23E)-3β-hydroxy-stigmasta-5,23-dien-28-one (11), together with 12 known compounds, were isolated from the green alga Caulerpa racemosa. The structures of the new compounds were elucidated by detailed analysis of spectroscopic data, and by comparison with data for related known compounds. The epimers (1 and 2) are two unusual diterpenoid lactones bearing a β-methyl-γ-substituted butenolide moiety, and 3 and 8 represent the first naturally occurring natural products with a hematinic acid ester group and 3,5-dimethylphenoxy functionality, respectively. The enzyme inhibitory activities of the isolated compounds were evaluated in vitro against PTP1B and related PTPs (TCPTP, CDC25B, LAR, SHP-1, and SHP-2). Compounds 3, 5, 6, and 9–14 exhibited different levels of PTP1B inhibitory activities with IC50 values ranging from 2.30 to 50.02μM. Of these compounds, 3, 9, and 11 showed the most potent inhibitory activities towards PTP1B with IC50 values of 2.30, 3.85, and 3.80μM, respectively. More importantly, the potent PTP1B inhibitors 3, 9, and 11 also displayed high selectivity over the highly homologous TCPTP and other PTPs. Also, the neuroprotective effects of the isolates against Aβ25-35-induced cell damage in SH-SY5Y cells were investigated. Compounds 10, 11, and 14 exhibited significant neuroprotective effects against Aβ25-35-induced SH-SY5Y cell damage with 11.31–15.98% increases in cell viability at 10μM. In addition, the cytotoxic activities of the isolated compounds were tested against the human cancer cell lines A-549 and HL-60.</description><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biological Products</subject><subject>Caulerpa - chemistry</subject><subject>Caulerpa racemosa</subject><subject>Cytotoxic activity</subject><subject>Diterpenes - chemistry</subject><subject>Diterpenes - pharmacology</subject><subject>HL-60 Cells</subject><subject>Humans</subject><subject>Molecular Structure</subject><subject>Neuroprotective activity</subject><subject>Neuroprotective Agents - chemistry</subject><subject>Neuroprotective Agents - pharmacology</subject><subject>Plant Extracts - chemistry</subject><subject>Plant Extracts - pharmacology</subject><subject>PTP1B inhibitory activity</subject><subject>Structure-Activity Relationship</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkDtv2zAURokiReO4_QFdAo1ZpN7Lh0SiXRKjTQsEyJLMBEVduTT0cEgpQP59ZdjNGGS6wz3fGQ5jXxEKBCy_7Yq69wUHlAViAQI_sBXKUuZCGDxjKzClzkGb8pxdpLQDAC4NfmLnXElTmVKs2I-bMDo_hWfK_DikKUwzDVPK2jj22fSXsm0kGjLXbV22cXNHce-y6Dz1Y3Kf2cfWdYm-nO6aPf76-bD5nd_d3_7ZXN_lXio-5bIiCZyAjPBOoGq54WBAiUZr1Fo5UFW9_JVunS7rulGtqrCWkldt3RoQa3Z19O7j-DRTmmwfkqeucwONc7JYliBBaG3egQpjqkpyuaB4RH0cU4rU2n0MvYsvFsEe-tqdXfraQ1-LaJe-y-bypJ_rnprXxf-gC_D9CNDS4zlQtMkHGjw1IZKfbDOGN_T_AJVYiQo</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Yang, Peng</creator><creator>Liu, Ding-Quan</creator><creator>Liang, Tong-Jun</creator><creator>Li, Jia</creator><creator>Zhang, Hai-Yan</creator><creator>Liu, Ai-Hong</creator><creator>Guo, Yue-Wei</creator><creator>Mao, Shui-Chun</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope></search><sort><creationdate>20150101</creationdate><title>Bioactive constituents from the green alga Caulerpa racemosa</title><author>Yang, Peng ; Liu, Ding-Quan ; Liang, Tong-Jun ; Li, Jia ; Zhang, Hai-Yan ; Liu, Ai-Hong ; Guo, Yue-Wei ; Mao, Shui-Chun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-47e402e0e93ca315f29209053d881885a057b2e058fa86bbd5f571b4427fbf903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biological Products</topic><topic>Caulerpa - chemistry</topic><topic>Caulerpa racemosa</topic><topic>Cytotoxic activity</topic><topic>Diterpenes - chemistry</topic><topic>Diterpenes - pharmacology</topic><topic>HL-60 Cells</topic><topic>Humans</topic><topic>Molecular Structure</topic><topic>Neuroprotective activity</topic><topic>Neuroprotective Agents - chemistry</topic><topic>Neuroprotective Agents - pharmacology</topic><topic>Plant Extracts - chemistry</topic><topic>Plant Extracts - pharmacology</topic><topic>PTP1B inhibitory activity</topic><topic>Structure-Activity Relationship</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Peng</creatorcontrib><creatorcontrib>Liu, Ding-Quan</creatorcontrib><creatorcontrib>Liang, Tong-Jun</creatorcontrib><creatorcontrib>Li, Jia</creatorcontrib><creatorcontrib>Zhang, Hai-Yan</creatorcontrib><creatorcontrib>Liu, Ai-Hong</creatorcontrib><creatorcontrib>Guo, Yue-Wei</creatorcontrib><creatorcontrib>Mao, Shui-Chun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Peng</au><au>Liu, Ding-Quan</au><au>Liang, Tong-Jun</au><au>Li, Jia</au><au>Zhang, Hai-Yan</au><au>Liu, Ai-Hong</au><au>Guo, Yue-Wei</au><au>Mao, Shui-Chun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bioactive constituents from the green alga Caulerpa racemosa</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>23</volume><issue>1</issue><spage>38</spage><epage>45</epage><pages>38-45</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>[Display omitted] Three diterpenoids, including a pair of epimers, racemobutenolids A and B (1 and 2), and 4′,5′-dehydrodiodictyonema A (3), an α-tocopheroid, α-tocoxylenoxy (8), and an 28-oxostigmastane steroid, (23E)-3β-hydroxy-stigmasta-5,23-dien-28-one (11), together with 12 known compounds, were isolated from the green alga Caulerpa racemosa. The structures of the new compounds were elucidated by detailed analysis of spectroscopic data, and by comparison with data for related known compounds. The epimers (1 and 2) are two unusual diterpenoid lactones bearing a β-methyl-γ-substituted butenolide moiety, and 3 and 8 represent the first naturally occurring natural products with a hematinic acid ester group and 3,5-dimethylphenoxy functionality, respectively. The enzyme inhibitory activities of the isolated compounds were evaluated in vitro against PTP1B and related PTPs (TCPTP, CDC25B, LAR, SHP-1, and SHP-2). Compounds 3, 5, 6, and 9–14 exhibited different levels of PTP1B inhibitory activities with IC50 values ranging from 2.30 to 50.02μM. Of these compounds, 3, 9, and 11 showed the most potent inhibitory activities towards PTP1B with IC50 values of 2.30, 3.85, and 3.80μM, respectively. More importantly, the potent PTP1B inhibitors 3, 9, and 11 also displayed high selectivity over the highly homologous TCPTP and other PTPs. Also, the neuroprotective effects of the isolates against Aβ25-35-induced cell damage in SH-SY5Y cells were investigated. Compounds 10, 11, and 14 exhibited significant neuroprotective effects against Aβ25-35-induced SH-SY5Y cell damage with 11.31–15.98% increases in cell viability at 10μM. In addition, the cytotoxic activities of the isolated compounds were tested against the human cancer cell lines A-549 and HL-60.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>25497963</pmid><doi>10.1016/j.bmc.2014.11.031</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2015-01, Vol.23 (1), p.38-45
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_1660403889
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Biological Products
Caulerpa - chemistry
Caulerpa racemosa
Cytotoxic activity
Diterpenes - chemistry
Diterpenes - pharmacology
HL-60 Cells
Humans
Molecular Structure
Neuroprotective activity
Neuroprotective Agents - chemistry
Neuroprotective Agents - pharmacology
Plant Extracts - chemistry
Plant Extracts - pharmacology
PTP1B inhibitory activity
Structure-Activity Relationship
title Bioactive constituents from the green alga Caulerpa racemosa
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-12T17%3A47%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bioactive%20constituents%20from%20the%20green%20alga%20Caulerpa%20racemosa&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Yang,%20Peng&rft.date=2015-01-01&rft.volume=23&rft.issue=1&rft.spage=38&rft.epage=45&rft.pages=38-45&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2014.11.031&rft_dat=%3Cproquest_cross%3E1660403889%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1639977424&rft_id=info:pmid/25497963&rft_els_id=S0968089614008189&rfr_iscdi=true